These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 18346939)
1. The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment. Guille C; Spencer S; Cavus I; Epperson CN Epilepsy Behav; 2008 Jul; 13(1):12-24. PubMed ID: 18346939 [TBL] [Abstract][Full Text] [Related]
2. A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy. Barone JC; Butler MP; Ross A; Patterson A; Wagner-Schuman M; Eisenlohr-Moul TA Front Neuroendocrinol; 2023 Oct; 71():101098. PubMed ID: 37619655 [TBL] [Abstract][Full Text] [Related]
3. Female reproductive steroids and neuronal excitability. Finocchi C; Ferrari M Neurol Sci; 2011 May; 32 Suppl 1():S31-5. PubMed ID: 21533709 [TBL] [Abstract][Full Text] [Related]
4. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085 [TBL] [Abstract][Full Text] [Related]
5. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Amin Z; Mason GF; Cavus I; Krystal JH; Rothman DL; Epperson CN Pharmacol Biochem Behav; 2006 Aug; 84(4):635-43. PubMed ID: 16860856 [TBL] [Abstract][Full Text] [Related]
6. GABA receptors, progesterone and premenstrual dysphoric disorder. Sundström Poromaa I; Smith S; Gulinello M Arch Womens Ment Health; 2003 Feb; 6(1):23-41. PubMed ID: 12715262 [TBL] [Abstract][Full Text] [Related]
7. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Hantsoo L; Epperson CN Neurobiol Stress; 2020 May; 12():100213. PubMed ID: 32435664 [TBL] [Abstract][Full Text] [Related]
8. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. N-Wihlbäck AC; Sundström-Poromaa I; Bäckström T Psychopharmacology (Berl); 2006 Jun; 186(3):388-401. PubMed ID: 16362406 [TBL] [Abstract][Full Text] [Related]
9. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition. Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469 [TBL] [Abstract][Full Text] [Related]
10. Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA. Hantsoo L; Payne JL Neurosci Biobehav Rev; 2023 Jun; 149():105168. PubMed ID: 37059403 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Tiranini L; Nappi RE Fac Rev; 2022; 11():11. PubMed ID: 35574174 [TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone and mood disorders. Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486 [TBL] [Abstract][Full Text] [Related]
13. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715 [TBL] [Abstract][Full Text] [Related]
14. Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy. Tuveri A; Paoletti AM; Orrù M; Melis GB; Marotto MF; Zedda P; Marrosu F; Sogliano C; Marra C; Biggio G; Concas A Epilepsia; 2008 Jul; 49(7):1221-9. PubMed ID: 18325018 [TBL] [Abstract][Full Text] [Related]
15. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder. Bixo M; Johansson M; Timby E; Michalski L; Bäckström T J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794 [TBL] [Abstract][Full Text] [Related]
16. Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder. Freeman EW Curr Psychiatry Rep; 2002 Dec; 4(6):435-40. PubMed ID: 12441023 [TBL] [Abstract][Full Text] [Related]
17. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study. Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697 [TBL] [Abstract][Full Text] [Related]
18. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli. Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875 [TBL] [Abstract][Full Text] [Related]
19. Trait-related changes in brain network topology in premenstrual dysphoric disorder. Dan R; Reuveni I; Canetti L; Weinstock M; Segman R; Goelman G; Bonne O Horm Behav; 2020 Aug; 124():104782. PubMed ID: 32470339 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis in menstrual cycle-linked CNS disorders. Bäckström T; Andersson A; Andreé L; Birzniece V; Bixo M; Björn I; Haage D; Isaksson M; Johansson IM; Lindblad C; Lundgren P; Nyberg S; Odmark IS; Strömberg J; Sundström-Poromaa I; Turkmen S; Wahlström G; Wang M; Wihlbäck AC; Zhu D; Zingmark E Ann N Y Acad Sci; 2003 Dec; 1007():42-53. PubMed ID: 14993039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]